Enterprise Therapeutics Publishes on Medicinal Chemistry of ETD001 | A Novel Inhaled ENaC Blocker for Treatment of Cystic Fibrosis
The paper describes the medicinal chemistry optimisation of a new [...]
Cytomos Secures £5M | To Scale Up Production of Cell-analysis Technology
New investment will allow Cytomos to drive sales of its [...]
TactoTek Secures $60 Million in Funding Led by Virala Group
With this funding, TactoTek will accelerate the adoption of IMSE [...]
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial (“INVINCIBLE-3 Study”) in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS)
Phase 1/2 data showed a median overall survival (“mOS”) of [...]
Boston Scientific Closes Acquisition of Axonics
Meghan Scanlon, senior vice president and president, Urology, Boston Scientific. [...]
How to Choose Bags & Cases for Medical Professionals and Students
So, how can one design bags and cases for medical [...]
Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market
Classys, which is listed on the KOSDAQ, is one of [...]
Stryker Launches Next-Generation of SurgiCount+
Now integrated with Stryker’s Triton technology, SurgiCount+ addresses two key [...]
Real-Time Assistive Voice App Turns Whispers to Speech
Real-Time Assistive Voice App: Millions of people the world over [...]
Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System
Nevro notes HFX iQ is the first and only SCS [...]